Oslo

Oslo has rapidly emerged as a premier European life sciences hub, distinguished by its world-class integration of biotechnology, pharmaceutical R&D and medical device innovation.

At the heart of this ecosystem is Oslo Science City, Norway’s first innovation district, which centralizes two-thirds of the nation’s research activities to accelerate the commercialization of healthcare solutions.

The city is globally recognized for its expertise in precision medicine, neuroscience and radiopharmaceuticals, supported by the specialized Oslo Cancer Cluster and its state-of-the-art biotech incubator.

Oslo’s leadership in health data analytics is bolstered by unique national registries and biobanks, providing a competitive edge for clinical trials and digital health startups.

Leading academic institutions like the University of Oslo (UiO) and Oslo University Hospital foster a culture of interdisciplinary collaboration, bridging the gap between basic science and medical technology.

The region also excels in one health and ocean health, leveraging Norway’s maritime heritage to drive biomedical innovation.

With massive investments in infrastructure, including the landmark Life Sciences Building, Oslo offers a fertile environment for venture capital and global pharma partnerships.

This thriving Nordic life science ecosystem is dedicated to developing sustainable healthcare services and next-generation therapeutics for a global market.

By combining AI-driven drug discovery with a robust public-private partnership model, Oslo is securing its position as a top-tier destination for life science investment and scientific talent in 2026.